Waverley Pharma Inc. (TSXV:WAVE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Feb 6, 2026
Market Cap810.00K -84.2%
Revenue (ttm)1.51M +2,016.3%
Net Income-367.11K
EPS-0.01
Shares Out54.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,005
Average Volume11,114
Open0.0400
Previous Closen/a
Day's Range0.0150 - 0.0400
52-Week Range0.0100 - 0.0400
Beta1.90
RSI42.92
Earnings DateApr 28, 2026

About Waverley Pharma

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol WAVE
Full Company Profile

Financial Performance

In 2024, Waverley Pharma's revenue was 475,373, an increase of 15.36% compared to the previous year's 412,090. Losses were -947,077, -57.42% less than in 2023.

Financial Statements